These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23544107)

  • 1. Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring.
    Shin JH; Greer B; Hakim CH; Zhou Z; Chung YC; Duan Y; He Z; Duan D
    PLoS One; 2013; 8(3):e59875. PubMed ID: 23544107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs.
    Gaiad TP; Araujo KP; Serrão JC; Miglino MA; Ambrósio CE
    PLoS One; 2014; 9(4):e93500. PubMed ID: 24713872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs.
    Kuraoka M; Nitahara-Kasahara Y; Tachimori H; Kato N; Shibasaki H; Shin A; Aoki Y; Kimura E; Takeda S
    PLoS One; 2018; 13(12):e0208415. PubMed ID: 30533017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gait analysis using accelerometry in dystrophin-deficient dogs.
    Barthélémy I; Barrey E; Thibaud JL; Uriarte A; Voit T; Blot S; Hogrel JY
    Neuromuscul Disord; 2009 Nov; 19(11):788-96. PubMed ID: 19800232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy.
    Kodippili K; Thorne PK; Laughlin MH; Duan D
    J Pathol; 2021 Aug; 254(5):589-605. PubMed ID: 33999411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.
    Fraysse B; Barthélémy I; Qannari EM; Rouger K; Thorin C; Blot S; Le Guiner C; Chérel Y; Hogrel JY
    BMC Musculoskelet Disord; 2017 Apr; 18(1):153. PubMed ID: 28403854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.
    Barthélémy I; Pinto-Mariz F; Yada E; Desquilbet L; Savino W; Silva-Barbosa SD; Faussat AM; Mouly V; Voit T; Blot S; Butler-Browne G
    Dis Model Mech; 2014 Nov; 7(11):1253-61. PubMed ID: 25261568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan.
    Kuraoka M; Aoki Y; Takeda S
    Exp Anim; 2021 Nov; 70(4):419-430. PubMed ID: 34135266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.
    Barthélémy I; Uriarte A; Drougard C; Unterfinger Y; Thibaud JL; Blot S
    PLoS One; 2012; 7(11):e48478. PubMed ID: 23185260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy.
    Kuraoka M; Kimura E; Nagata T; Okada T; Aoki Y; Tachimori H; Yonemoto N; Imamura M; Takeda S
    Am J Pathol; 2016 May; 186(5):1302-12. PubMed ID: 26963343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early signs of gait deviation in Duchenne muscular dystrophy.
    Doglio L; Pavan E; Pernigotti I; Petralia P; Frigo C; Minetti C
    Eur J Phys Rehabil Med; 2011 Dec; 47(4):587-94. PubMed ID: 21912365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait pattern in Duchenne muscular dystrophy.
    D'Angelo MG; Berti M; Piccinini L; Romei M; Guglieri M; Bonato S; Degrate A; Turconi AC; Bresolin N
    Gait Posture; 2009 Jan; 29(1):36-41. PubMed ID: 18656361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of muscular co-activation and gait variability in children with Duchenne muscular dystrophy: A 2-year follow-up study.
    Rinaldi M; Petrarca M; Romano A; Vasco G; D'Anna C; Bibbo D; Schmid M; Castelli E; Conforto S
    Clin Biomech (Bristol, Avon); 2020 Aug; 78():105101. PubMed ID: 32652381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eccentric contraction injury in dystrophic canine muscle.
    Childers MK; Okamura CS; Bogan DJ; Bogan JR; Petroski GF; McDonald K; Kornegay JN
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1572-8. PubMed ID: 12422328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.